Skip to content

AcrySof™ IQ Vivity™ DAT515 (REF DAT515.225)Recalls & reported problems

Alcon Laboratories, Inc. · Sterile UV Absorbing Acrylic Foldable Aspheric Wavefront-Shaping Toric Posterior Chamber Intraocular Lenses · Class 3 · Implant

All models of AcrySof IQ Vivity (225)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380652428781), received between Apr 30, 2021 and Nov 7, 2021 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Break1
  • Material Split, Cut or Torn1

Patient problems

  • Blurred Vision1
  • No Clinical Signs, Symptoms or Conditions1
  • Visual Impairment1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 7, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A BILLING DIRECTOR REPORTED AFTER THE INTRAOCULAR LENS (IOL) IMPLANTATION THE PATIENT HAD EXPERIENCED BLURRED VISION HENCE THE LENS WAS EXPLANTED IN A SECONDARY SURGERY AND WAS REPLACED WITH A DIFFERENT LENS MODEL. THE CLINICAL REASON FOR THE EXPLANT WAS REFRACTIVE SURPRISE. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: Blurred Vision; Visual Impairment

    MAUDE report 12764081 ↗
  • MalfunctionApr 30, 2021Break; Material Split, Cut or Torn; Break; Material Split, Cut or Torn

    A NURSE REPORTED THAT DURING A CATARACT SURGERY WITH AN INTRAOCULAR LENS (IOL) IMPLANTATION, THE LENS EMERGED FROM THE INJECTOR IN PIECES. THE TRAILING HAPTIC WAS IN PIECES AND THE OPTIC WAS SHATTERED AT THE INSERTION POINTS OF THE SHORN HAPTIC. THE LENS MATERIAL WAS BRITTLE AND SHARD-LIKE. THE IOL WAS REPLACED IN THE SAME PROCEDURE WITH NO REPORTED HARM TO THE PATIENT. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11752204 ↗

Other Extended depth of focus intraocular lens devices

All Extended depth of focus intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page